Table 1.

Summary of characteristics of 267 patients at diagnosis

CharacteristicsNumber/value%Range
Age, median, years 63.0  29-94 
Sex    
 Female 125 47  
 Male 142 53  
Clinical subtype    
 Chronic type 149 56  
 Smoldering type 118 44  
Admitted to    
 Hematology Department 184 69  
 Dermatology Department 83 31  
Neutrophil count, median, ×109/L 4.1  0.0-36.6 
Lymphocyte count, median, ×109/L 4527  480-80 567.5 
Abnormal lymphocyte count, median, ×109/L 1554  0.0-78 826 
Hemoglobin level, median, g/dL 13.6  4.2-17.7 
Platelet count, median, ×109/L 220  63-560 
Serum total protein, median, g/dL 7.1  4.8-8.9 
Serum albumin, median, g/dL 4.2  2.3-5.4 
BUN, median, mg/dL 13.4  3.5-70.0 
LDH, median, IU/L 246  122-926 
LDH > ULN, % 134 50  
Soluble IL-2R, median, U/mL 2796  192-162 000 
Increased CRP present 83 31  
Stage    
 I-II 29 11  
 III-IV 238 89  
ECOG performance status    
 0-1 248 93  
 2-4 19  
B symptoms present 26 10  
Number of lymph node lesions, median, range  0-11 
Number of extranodal sites, median, range  0-4 
Total number of involved lymph nodes and extranodal lesions, median, range  0-13 
Bone marrow involvement present 39 15  
Liver involvement present  
Spleen involvement present 13  
Skin lesions present 162 61  
Lung involvement present 12  
CharacteristicsNumber/value%Range
Age, median, years 63.0  29-94 
Sex    
 Female 125 47  
 Male 142 53  
Clinical subtype    
 Chronic type 149 56  
 Smoldering type 118 44  
Admitted to    
 Hematology Department 184 69  
 Dermatology Department 83 31  
Neutrophil count, median, ×109/L 4.1  0.0-36.6 
Lymphocyte count, median, ×109/L 4527  480-80 567.5 
Abnormal lymphocyte count, median, ×109/L 1554  0.0-78 826 
Hemoglobin level, median, g/dL 13.6  4.2-17.7 
Platelet count, median, ×109/L 220  63-560 
Serum total protein, median, g/dL 7.1  4.8-8.9 
Serum albumin, median, g/dL 4.2  2.3-5.4 
BUN, median, mg/dL 13.4  3.5-70.0 
LDH, median, IU/L 246  122-926 
LDH > ULN, % 134 50  
Soluble IL-2R, median, U/mL 2796  192-162 000 
Increased CRP present 83 31  
Stage    
 I-II 29 11  
 III-IV 238 89  
ECOG performance status    
 0-1 248 93  
 2-4 19  
B symptoms present 26 10  
Number of lymph node lesions, median, range  0-11 
Number of extranodal sites, median, range  0-4 
Total number of involved lymph nodes and extranodal lesions, median, range  0-13 
Bone marrow involvement present 39 15  
Liver involvement present  
Spleen involvement present 13  
Skin lesions present 162 61  
Lung involvement present 12  

BUN, blood urea nitrogen; CRP, C-reactive protein; ECOG, Eastern Cooperative Oncology Group; IL-2R, interleukin-2 receptor; ULN, upper limit of normal.

The sIL-2R level by picogram per milliliter may be converted to units per milliliter, using the formula: value (pg/mL) × 0.113.

or Create an Account

Close Modal
Close Modal